![Luciano Marraffini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Luciano Marraffini
Founder at Eligo Bioscience SA
Profile
Luciano Marraffini is the founder of Intellia Therapeutics, Inc. (founded in 2014) and Eligo Bioscience SA (founded in 2014).
He holds a doctorate degree from The University of Chicago.
Luciano Marraffini active positions
Companies | Position | Start |
---|---|---|
Eligo Bioscience SA
![]() Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Founder | 01/05/2014 |
Former positions of Luciano Marraffini
Companies | Position | End |
---|---|---|
INTELLIA THERAPEUTICS, INC. | Founder | - |
Training of Luciano Marraffini
The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INTELLIA THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Eligo Bioscience SA
![]() Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Health Services |
- Stock Market
- Insiders
- Luciano Marraffini